The FDA sent formal warning letters to the makers of ADHD medications for inappropriate and misleading information in their advertising.

The warning applied to the makers of Strattera (Eli Lilly), Adderall XR and Vyvanse (Shire) and Concerta (Ortho-MacNeil).

In summary - the concerns of the FDA were that the ads or promotional materials in question were overstating benefits and not disclosing the risks.

To read more, visit CNN’s article here.

=================================================

Written by Dr. Kenny Handelman - The ADHD Doctor


To find get a FREE special report on ADD/ADHD Medication, visit: Medication Mastery

==================================================

Share This

Email this post to a friend:

Related Posts

• The Dollars and Cents of ADHD
• ADHD World Takes on Facebook and Pharma
• ADHD Medication: Are Generics The Same?
• Ty Pennington: Harnessing The Power of Celebrity For ADHD
• Adult ADHD Symptoms Are Different

This entry was posted on Wednesday, October 1st, 2008 at 10:19 am and is filed under ADHD General Information. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.